True, except for patients age 55+. They did not receive the initial half-concentration dose. That's almost certainly why those receiving the half-concentratio

True, except for patients age 55+. They did not receive the initial half-concentration dose. That's almost certainly why those receiving the half-concentration dose experienced much higher efficacy (90% vs 62%) — they were younger and had fewer co-morbidities.